A Study of Abemaciclib in Combination With Sunitinib in Metastatic Renal Cell Carcinoma
Condition: Renal Cell Carcinoma Metastatic Interventions: Drug: Abemaciclib; Drug: Sunitinib Sponsors: Milton S. Hershey Medical Center; Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials